Assignment:

1. What are some potential risks or drawbacks from changing or expanding the scope of Banner University of Arizona’s (Tucson Arizona) service line, in order to reach new markets?
2. Are there any benefits for doing so?
3. Does the “dog” (organization) wag the “tail” (marketing), or is it the other way around?
Reading:

Francer, J., Izquierdo, J. Z., Music, T., Narsai, K. Nikidis, C., Simmonds, H., & Woods, P. (2014). Ethical pharmaceutical promotion and communications worldwide: codes and regulations. Philosophy, ethics, and humanities in medicine, 9(1), p. 7. Available in the Trident Online Library.
Geangu, I. P., Dumitru, I., & Gârdan, D. (2013). Ethical and legal aspects of marketing activiity in the field of dental healthcare services. Contemporary Readings in Law and Social Justice, 5(2), 904-918.
Gitterman, A. (2013). Ethical issues and practical challenges raised by internal investigations in the life sciences industry. Defense Counsel Journal, 80(4), 372-394
Glied, S., & Oellerich, D. (2014). Two-generation programs and health. The Future of Children, 24(1).
Hancher-Rauch, H., Hicks, L., Mayol, M. H., & Casselman, K. (2013). SAVING YOUR WELLNESS PROGRAM. Journal of Physical Education, Recreation & Dance, 84(6), 29-34.
Hanna, L., Barry, J., B.Sc, Donnelly, R., Hughes, F., M.Pharm, Jones, D., D.Sc, Laverty, G., Ryan, C.,. (2014). Using debate to teach pharmacy students about ethical issues. American Journal of Pharmaceutical Education, 78(3), 57.
Horwitz, J. R., Kelly, B. D., & DiNardo, J. E. (2013). Wellness incentives in the workplace: Cost savings through cost shifting to unhealthy workers. Health Affairs, 32(3), 468-76.
Stichler, Jaynelle F. (2013). Ethical considerations in healthcare design and construction. HERD: Health Environments Research & Design Journal, 6(4), 5-9.
Womack, C. A. (2013). Ethical and epistemic issues in direct-to-consumer drug advertising: Where is patient agency? Medicine, Health Care, and Philosophy, 16(2), 275-80.Assignment:

Assignment:
The objective of the project is to analyze the risk and return structure of the investment.
Methodology: when it comes to analyzing the risk and return structure of investments, there are numerous measures one could utilize. Over and above “standard” measures, this project requires two additional measures?down-market beta and GARCH volatility, which are respectively estimated via the dual-beta and GARCH models.
Dual-beta model:
The dual-beta model is an extension of the standard Capital Asset Pricing Model (CAPM). It estimates separately the parameters for up-market, when the daily return for the market index is non-negative, and down-market, when the daily return for the market index is negative. The dual-beta model can thus be expressed as:

Assignment:
The objective of the project is to analyze the risk and return structure of the investment.
Methodology: when it comes to analyzing the risk and return structure of investments, there are numerous measures one could utilize. Over and above “standard” measures, this project requires two additional measures?down-market beta and GARCH volatility, which are respectively estimated via the dual-beta and GARCH models.
Dual-beta model:
The dual-beta model is an extension of the standard Capital Asset Pricing Model (CAPM). It estimates separately the parameters for up-market, when the daily return for the market index is non-negative, and down-market, when the daily return for the market index is negative. The dual-beta model can thus be expressed as: